Synbio Tech Inc. (TPEX: 1295)
Health Care · Biotechnology · TW
NT$48.35
-3.49% today · -54.2% 1Y
Synbio Tech Inc. (TPEX: 1295) operates in the Biotechnology industry within the Health Care sector. The company is valued at $51.37M and employs 92 people.
Over the last twelve months the share price has lost 54.2%, trading between 44.05 and 123.50.
Tweenvest scores Synbio Tech Inc. across four factors: quality 74/100, value 72/100, dividend 100/100. Its strongest factor is dividend.
1295 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $51.37M
- Revenue (TTM)
- $31.64M
- P/E
- 11.76
- EPS
- 4.11
- Dividend yield
- 6.20%
- Beta (5Y)
- 0.50
- 52-week high
- NT$123.50
- 52-week low
- NT$44.05
- Avg volume (3M)
- —
- Shares outstanding
- 34.47M
- Employees
- 92
- Next earnings
- —
About Synbio Tech Inc.
Synbio Tech Inc. operates as a biotechnology enterprise, primarily focusing on the development and production of probiotics and their various applications. The company also handles the marketing and distribution of several products in China, such as lactic acid bacteria (LAB) beverages, LAB powders formulated for human health, and specialized probiotic solutions for the agriculture, forestry, fishery, and animal husbandry sectors. Established on June 1, 2000, the firm maintains its principal office in Kaohsiung City, Taiwan.
- ISIN
- TW0001295004
- Founded
- 2000
- Listed since
- Dec 13, 2023
- Exchange
- Taipei Exchange
- Currency
- TWD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| UBI Pharma Inc.UNQ: 6562 | $52.10M | NT$— | — |
| CG Invites Co., Ltd.KOSDAQ: A083790 | $52.02M | ₩902.00 | -3.01% |
| CellSeed Inc.TSE: 7776 | $51.50M | ¥206.00 | -2.37% |
| RenovoRx, Inc.NasdaqCM: RNXT | $51.45M | $1.14 | -10.94% |
| Prestige BioPharma LimitedKOSE: A950210 | $51.30M | ₩5,690.00 | -4.53% |
| Nano Holdings, Inc.TSE: 4571 | $51.13M | ¥89.00 | +12.66% |
| Uni-Bio Science Group LimitedSEHK: 690 | $50.98M | HK$0.07 | -4.29% |
| Rein Therapeutics Inc.NasdaqCM: RNTX | $50.92M | $0.59 | -25.65% |
Figures last refreshed Oct 18, 2026.